About
Ward Capoen is a Partner at V-Bio Ventures, which he joined in 2016. He holds a PhD in molecular biology research and has worked at VIB/UGent, the John Innes Centre, and Harvard Medical School. His expertise spans both plant and animal models, and ranges from fundamental to translational research. Before joining V-Bio Ventures, Ward worked as a senior analyst at Candriam Investors Group (formerly Dexia Asset Management), where he was responsible for investment analysis of early-stage listed biotech companies. Ward holds a PhD in Biotechnology from the University of Gent, Belgium, and an MBA from Vlerick Business School, Leuven, Belgium.
Sign up to see Ward Capoen's full profile
Access investment thesis, focus areas, bio, and contact details for Ward Capoen and 22,000+ other VC professionals.
V-Bio Ventures
Ghent, BE